银诺医药-B（02591.HK）股东结构 - 机构持仓、大股东与内部人士

主要股东最新
股东
Guangzhou Nuopa Enterprise Management Partnership (Limited Partnership)	14.31%	6,537.47 万	0.00%	+0	2025/12/31
Qinghua WangFounder, GM & Executive Chairman	10.12%	4,621.96 万	0.00%	+0	2025/12/31
Hong Kong Invengen Pharmaceutical Technology Co., Limited	5.97%	2,725.36 万	0.00%	+0	2025/12/31
Korea Investment Partners Co. Ltd.	5.94%	2,713.42 万	0.13%	+57.78 万	2026/08/25
Guangzhou Industrial Investment Biomedical and Health Special Master Fund Partnership Enterprise	4.95%	2,259.48 万	0.00%	+0	2025/12/31
Centurium Capital Management Ltd.	4.43%	2,023.04 万	0.00%	+0	2025/08/15
V Star Capital	4.37%	1,996.19 万	1.18%	-538.30 万	2026/09/01
Shenzhen Co-win Venture Capital Investments Limited	3.89%	1,778.64 万	1.92%	-877.00 万	2026/09/03
BioTrack Capital	3.34%	1,526.87 万	0.00%	+0	2025/08/15
Hong Kong Innogen Pharmaceutical Technology Co., Limited	2.79%	1,275.02 万	0.00%	+0	2025/12/31
Shenzhen Qianhai Sanhe Equity Fund Management Co., Ltd.	2.64%	1,206.67 万	0.00%	+0	2025/08/15
Shenzhen Cowin Asset Management Co.,Ltd.	2.50%	1,140.47 万	1.32%	-601.00 万	2026/09/03
Shenzhen Mingzhe Asset Management Co., Ltd.	1.85%	844.67 万	0.00%	+0	2025/08/15
CICC Capital Management Co., Ltd.	1.72%	784.34 万	0.00%	+0	2025/12/31
Suzhou Longao Fan Artificial Intelligence High-tech Investment Center (Limited Partnership)	1.55%	708.06 万	0.00%	+0	2025/08/15
Shanghai Nuolin Pharmaceutical Partnership (Limited Partnership)	1.53%	700.87 万	0.00%	+0	2025/08/15
Deqing Puying Investment Management Partnership Enterprise (L.P.)	1.32%	603.34 万	0.00%	+0	2025/08/15
Korea Investment Partners (Shanghai) Venture Capital Management Co., Ltd.	1.23%	561.84 万	1.23%	+561.84 万	2026/08/25
Xiamen Zhisheng Investment Management Co., Ltd.	1.19%	543.00 万	0.00%	+0	2025/08/15
China Everbright Assets Management Ltd.	1.06%	482.67 万	0.00%	+0	2025/12/31